Remove Chemotherapy Remove Download Remove Packaging
article thumbnail

Solving the taxing problems of taxanes?

European Pharmaceutical Review

Despite advances with targeted and immuno-oncology therapies, chemotherapies remain a cornerstone of cancer treatment for many tumour types – a reflection of their significant anti?tumour While highly effective, taxanes also exhibit several of the typical limitations associated with systemic chemotherapies. tumour effects.

article thumbnail

CMO Moves: Regulatory catalysts for drug manufacturing- February

Pharmaceutical Technology

Contract manufacturing organizations (CMOs) not only produce the active pharmaceutical ingredient (API) at the heart of a therapy, but are also responsible for the sterile manufacturing and packaging of liquid and inhalational drug constituents and packaging, depending on the needs of the particular therapy.